Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 36
- Registration Number
- NCT01659892
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 34
- Registration Number
- NCT01659931
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 35
- Registration Number
- NCT01659918
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 35
- Registration Number
- NCT01659905
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT01591889
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions
- Conditions
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 42
- Registration Number
- NCT01570907
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions
- Conditions
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 56
- Registration Number
- NCT01570959
- Locations
- ๐บ๐ธ
Global Medical Institutes/Princeton Medical Institute, Princeton, New Jersey, United States
๐บ๐ธCollaborative Neuroscience Network, Inc., Garden Grove, California, United States
๐บ๐ธCommunity Clinical Research, Inc., Austin, Texas, United States
Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions
- Conditions
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 42
- Registration Number
- NCT01570894
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT01367626
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT01367652
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States